PSC recurrence post liver transplantation: retransplantation justified or not?

Affiliations

Free article

Comment

Cynthia Tsien et al. Transpl Int. 2021 Oct.

Free article

. 2021 Oct;34(10):1754-1755.

doi: 10.1111/tri.14014.

¹ Ajmera Transplant Program, Department of Medicine, University of Toronto, Toronto, ON, Canada.

No abstract available

Comment on

Recurrence of primary sclerosing cholangitis after liver transplantation - analysing the European Liver Transplant Registry and beyond.
Visseren T, Erler NS, Polak WG, Adam R, Karam V, Vondran FWR, Ericzon BG, Thorburn D, IJzermans JNM, Paul A, van der Heide F, Taimr P, Nemec P, Pirenne J, Romagnoli R, Metselaar HJ, Darwish Murad S; European Liver and Intestine Transplantation Association (ELITA). Visseren T, et al. Transpl Int. 2021 Aug;34(8):1455-1467. doi: 10.1111/tri.13925. Epub 2021 Jun 28. Transpl Int. 2021. PMID: 34028110 Free PMC article.

1. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR. Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420.
1. Brown RS. Hepatitis C and liver transplantation. Nature 2005; 436: 973.
1. Graziadei IW, Wiesner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology 1999; 30: 1121.
1. Ravikumar R, Tsochatzis E, Jose S, et al. Risk factors for recurrent primary sclerosing cholangitis after liver transplantation. J Hepatol 2015; 63: 1139.
1. Gordon FD, Goldberg DS, Goodrich NP, et al. Recurrent primary sclerosing cholangitis in the adult-to-adult living donor liver transplantation cohort study: comparison of risk factors between living and deceased donor recipients. Liver Transpl 2016; 22: 1214.